Page 10 - OHKF_Biotech_EN

Executive summary With regard to the intellectual property (IP) regime, we recommend research institutes and enterprises to utilise said resources in the
that the National Intellectual Property Administration set up a
Loop, provided that appropriate risk management protocols are
in place.
subsidiary in the Loop, with a view to expedite approval of patent
applications by enterprises registered in the Loop. We also
Moreover, to speed up approval of the import of bio-materials and
recommend the Administration to make reference to Hong Kong’s
patent re-registration system and recognise standard patents
authorities allow Shenzhen customs and market regulators to
granted by Hong Kong’s Intellectual Property Department’s original medical devices, we recommend that the competent Central
grant patent (OGP) system, with a trial scheme to be run in the further improve the inspection and quarantine procedures for
GBA first. importing bio-materials, expedite testing and allow enterprises on
the “White List” to import bio-materials. The relevant Central
In relation to the registration and launch of new drugs, the National authorities can also authorise the use of unregistered imported
Medical Products Administration can consider delegating certain medical devices for R&D and testing purposes by Loop-based
powers in new drug approval, so that the GBA sub-centres biomedical enterprises and specific healthcare organisations in
established in the Shenzhen park of the Loop can be tasked with Shenzhen.
new drug approval procedures for relevant organisations and
enterprises in the Loop and all-stage intervention for the With development of the Loop as its focus, the present study
approval procedures. approaches collaboration in biotech as an entry point to draw up
seven major recommendations to the Central Government and the
governments of Hong Kong and Shenzhen with regard to the
Recommendation 7 Facilitating passage collaborative development of “one river, two banks” and “one
of bio-materials and medical devices zone, two parks”. Under these, 19 proposals are put forward
between Hong Kong and Shenzhen (see Figure 1). We believe that these recommendations can help

Finally, although cross-border flow of goods in specific areas into overcome barriers hampering HK-SZ collaboration and foster
the Loop has seen improvement, the Mainland’s export regime in the complementary cooperation of the two cities, so that we can
relation to biological materials and samples still needs to be seize the golden opportunities under the national plan to create
optimised. We recommend the establishment of a subsidiary of a biomedical powerhouse in the GBA that promotes
the Human Genetic Resources Administration in the Loop, biotechnological innovations at the cutting edge of the global
optimisation of the Mainland’s export regime in relation to scientific community.
biological samples, and improvement of entry-exit inspection and
quarantine procedures for human genetic resources by Mainland
and Hong Kong Customs, so that eligible Hong Kong institutions,

8